Rigel Pharmaceuticals reported $40.81M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agenus AGEN:US USD 64.42M 1.07M
Amgen AMGN:US USD 3.91B 504M
Anika Therapeutics ANIK:US USD 28.58M 14.46M
Applied Genetic Technologies AGTC:US USD 17.34M 705K
Arrowhead Research ARWR:US USD 115.4M 10.08M
AstraZeneca AZN:LN USD 9.74B 495M
Astrazeneca AZN:US USD 9.74B 495M
Biomarin Pharmaceutical BMRN:US USD 507.76M 13.12M
Bristol Myers Squibb BMY:US USD 8.75B 552M
Celldex Therapeutics CLDX:US USD 28.1M 8.46M
Daiichi Sankyo 4568:JP JPY 266.28B 20.35B
Eli Lilly And LLY:US USD 5.27B 12.8M
Halozyme Therapeutics HALO:US USD 128.4M 10.09M
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Immunogen IMGN:US USD 92.8M 17.59M
Intrexon XON:US USD 24.34M 2.74M
Karyopharm Therapeutics KPTI:US USD 66.98M 15.6M
Ligand Pharmaceuticals LGND:US USD 65.45M 9.36M
Macrogenics MGNX:US USD 66.69M 1.13M
Neurocrine Biosciences NBIX:US USD 300.1M 93.4M
Pfizer PFE:US USD 13.23B 2.41B
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Rigel Pharmaceuticals RIGL:US USD 40.81M 1.97M
Sangamo Biosciences SGMO:US USD 81.35M 6.24M
Ultragenyx Pharmaceutical RARE:US USD 315.77M 84.83M
Veracyte VCYT:US USD 85.27M 1.67M